[1] 张 檀,周丽萍,陈志央.孕中期血清产前筛查与不良妊娠结局的相关性分析[J].中华医学遗传学杂志,2012,29(5):608-610. ZHANG Tan, ZHOU Li-ping, CHEN Zhi-yang. Analysis the correlation between second trimester prenatal serum screening and adverse pregnancy outcomes [J]. Chinese Journal of Medical Genetics, 2012,29(5):608-610.(in Chinese)
[2] DUGOFF L. First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes [J]. Obstet Gynecol, 2010, 115(5):1052-1061.
[3] D'ANTONIO F, RIJO C, THILAGANATHAN B, et al. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications[J]. Prenat Diagn, 2013,33(9):839-847.
[4] LAURA J P, REBECCA B, ROBERT C, et al. Association between eclampsia, maternal characteristics, and abnormal levels of first and second trimester serum biomarkers[J]. Reprod Sci, 2014,21(3):297A.
[5] ODIBO A, ZHONG Y, KATHERINE R, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia[J]. Placenta, 2011,32(8):598-602.
[6] UCCELLA S, COLOMBO G F, BULGHERONI C M, et al. First-trimester maternal serum screening and the risk for fetal distress during labor [J]. Am J Obstet Gynecol, 2009,201(2):166.e1-6.
[7] KARIM J N, SAU A. Low pregnancy associated plasma protein-A in the 1st trimester: is it a predictor of poor perinatal outcome?[J]. J Obstet Gynaecol, 2013, 33(4):351-354.
[8] LAKHI N, GOVIND A, MORETTI M, et al. Maternal serum analytes as markers of adverse obstetric outcome[J]. Obstet Gynecol, 2012,14(4):267-273.
[9] 张 旸,翟 妍,刘 浩,等.中孕期母血清学标志物与不良妊娠结局的相关性分析[J].中华医学杂志,2014,94(5):379-381. ZHANG Yang, ZAI Yan, LIU Hao, et al. Relationship of mid-trimester serum screening markers and adverse pregnancy outcomes [J]. National Medical Journal of China, 2014,94(5):379-381. (in Chinese)
[10] 王新红,黄瑞萍,虞 斌,等.孕中期母血甲胎蛋白水平与不良妊娠结局的关系研究[J].解放军医学杂志,2010,35(9):1157-1158. WANG Xin-hong, HUANG Rui-ping, YU Bin, et al. Relationship between second-trimester maternal serum alpha-fetoprotein levels and adverse pregnancy outcomes[J]. Medical Journal of Chinese People's Liberation Army, 2010,35(9):1157-1158. (in Chinese)
[11] YUAN W, CHEN L, BERNAL A L. Is elevated maternal serum alpha-fetoprotein in the second trimester of pregnancy associated with increased preterm birth risk? A systematic review and meta-analysis[J]. Eur J Obstet Gynecol Reprod Biol, 2009,145(1):57-64.
[12] KRAUSE T G, CHRISTENS P, WOHLFAHRT J, et al. Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome[J]. Obstet Gynecol, 2001,97(2):277-282.
[13] KIRAN T S, BETHEL J, BHAL P S. Correlation of abnormal second trimester maternal serum alpha-fetoprotein (MSAFP) levels and adverse pregnancy outcome[J]. J Obstet Gynecol, 2005,25(3):253-256.
[14] WALD N J, CUCKLE H S, DENSEM, J W, et al. Maternal serum screening for Down syndrome in early pregnancy[J].Br Med J,1988,297(6653):883-887.
[15] 周 倩,胡晓雨,蒋宇林,等. 妊娠中期唐氏综合征筛查血清标志物异常与不良妊娠结局[J].中华围产医学,2013,16(9):555-560. ZHOU Qian, HU Xiao-yu, JIANG Yu-lin, et al. Maternal serum markers for Down syndrome screening in second-trimester and its relations with adverse pregnant outcomes[J]. Chinese Journal of Perinatal Medicine, 2013,16(9):555-560. (in Chinese)
[16] 谢 幸.妇产科学[M].8版.北京:人民卫生出版社,2013:64-120. XIE Xing. Obstetrics and Gynecology[M].8th ed. Beijing: People's Medical Publishing House, 2013:64-120. (in Chinese)
[17] VAN RAVENSWAAIJ R, TESSELAAR-VAN DER GOOT M, DE WOF S, et al. First-trimester serum PAPP-A and fβ-hCG concentrations and other maternal characteristics to establish logistic regression-based predictive rules for adverse pregnancy outcome[J].Prenat Diagn, 2011,31(1):50-57.
[18] 黎冬梅,赵飞飞,张云霞,等.中孕期母体血清游离β-HCG水平过高与不良妊娠结局相关性的研究[J].现代妇产科进展, 2011,20(3):186-189. LI Dong-mei, ZHAO Fei-fei, ZHANG Yun-xia, et al. Association between the abnormal maternal serum free β-HCG levels in second trimester and some adverse pregnancy outcomes [J]. Progress in Obstetrics and Gynecology, 2011,20(3):186-189. (in Chinese)
[19] SUMMERS A M, LANGLOIS S, WYATT P, et al. Prenatal screening for fetal aneuploidy [J]. J Obstet Gynaecol Can, 2007,29(2):146-161.
[20] CRAIG W Y, PALOMAKI G, ROBERSON M, et al. Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester [J]. Prenat Diagn, 2011,31(1):616-618.
[21] CRAIG W Y, ROBERSON M, PALOMAKI G E, et al. Prevalence of steroid sulfatase deficiency in California according to race and ethnicity[J]. Prenat Diagn, 2010,30(9):893-898.
[22] GAGNON A, WILSON R D, AUDIBERT F, et al. Obstetrical complications associated with abnormal maternal serum markers analytes [J]. J Obstet Gynaecol Can,2008,30(10):918-949.
[23] 向淑真,沈宗姬.动态监测抑制素A在预测早期先兆流产结局中的临床意义[J]. 中国妇幼保健,2010,25(4):512-515. XIANG Shu-zhen, SHEN Zong-ji. Clinical significance of dynamic monitoring of inhibin A in prediction of outcomes of early threatened abortion [J]. China Maternal and Child Health, 2010, 25(4):512-515. (in Chinese)
[24] OLSEN R N, WOELKERS D, DUNSMOOR-SU R, et al. Abnormal second-trimester serum analytes are more predictive of preterm preeclampsia [J]. Am J Obstet Gynecol, 2012,207(3):221-228.
[25] ROEDER H A, DEJBAKHSH S Z, PARAST M M, et al. Abnormal uterine artery Doppler velocimetry predicts adverse outcomes in patients with abnormal analytes[J]. Pregnancy Hypertens, 2014,4(4):296-301.